Publications by authors named "Nakamori K"

Oral bacteria cause tooth caries and periodontal disease. Much research is being conducted to prevent both major oral diseases by rendering dental materials' antimicrobial potential. However, such antimicrobial materials are regarded as 'combination' products and face high hurdles for regulatory approval.

View Article and Find Full Text PDF

Obesity is a worldwide health problem with a rapidly rising incidence. In organ transplantation, increasing numbers of patients with obesity accumulate on waiting lists and undergo surgery. Obesity is in general conceptualized as a chronic inflammatory disease, potentially impacting alloimmune response and graft function.

View Article and Find Full Text PDF

Both age and biological sex affect transplantation outcomes. We have recently shown in a large volume clinical analysis utilizing the SRTR data that graft survival is inferior in young female kidney transplant recipients. In this multi-factorial analysis, older female recipients presented with a trend towards improved transplant outcomes compared to both young female recipients and male recipients of any age.

View Article and Find Full Text PDF

Background: Living kidney transplant donors are classified as stage 3 chronic kidney disease after kidney donation. For this reason, we provide daily lifestyle guidance, such as blood pressure and weight management before surgery, and dietary counseling focused on salt restriction. We emphasize providing lifestyle guidance after kidney donation.

View Article and Find Full Text PDF
Article Synopsis
  • - Bladder cancer (BC) patients can experience shrinkage due to radiation-induced fibrosis, and specific microRNAs (miRNAs) are linked to this injury and overall survival.
  • - In a study of three Japanese BC patients, certain miRNAs (such as hsa-miR-130a and hsa-miR-200c) were highly expressed in those with fibrotic bladder shrinkage compared to patients with intact bladder function.
  • - Analysis of 409 BC patients revealed that high expression of specific miRNAs correlated with significantly longer median survival, indicating a potential role for these miRNAs in predicting patient outcomes and targeting profibrotic cytokines.
View Article and Find Full Text PDF
Article Synopsis
  • There is currently limited understanding of how alterations in fibroblast growth factor receptor 3 (FGFR3) affect bladder cancer (BLCA) and its tumor microenvironment (TME).
  • A study involving multi-omics analysis of BLCA tissues showed that aFGFR3 alterations are found in 44% of non-muscle invasive cases and 15% of muscle-invasive cases, affecting their immune response and tumor characteristics.
  • Notably, the LumP subtype in aFGFR3 cases responded significantly better to checkpoint inhibitors compared to their intact FGFR3 counterparts, suggesting that FGFR3 status influences treatment outcomes in bladder cancer.
View Article and Find Full Text PDF

Purpose: This study investigates the utility of ureteroscopic surgery (URS) as an alternative to radical nephroureterectomy (RNU) in managing upper tract urothelial carcinoma (UTUC), with a focus on survival outcomes and re-evaluation of current the European Association of Urology guidelines criteria.

Methods: We conducted a retrospective, multi-institutional review of 143 UTUC patients treated with URS (n = 35) or RNU (n = 108). Clinicopathological factors were analyzed, and survival outcomes were assessed using Kaplan-Meier analysis and Cox proportional-hazards models.

View Article and Find Full Text PDF

Background: Immune checkpoint inhibitors can cause various immune-related adverse events (irAEs). This study aimed to evaluate the association between the incidence of irAEs and oncological outcomes of metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab as first-line therapy.

Patients And Methods: We retrospectively analyzed data from 69 patients with mRCC treated with nivolumab plus ipilimumab as first-line therapy between September 2018 and September 2021 at 4 institutions.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify simple indicators from daily clinical practice that can predict the objective response to pembrolizumab in metastatic urothelial carcinoma patients, which is known for leading to better survival outcomes.
  • The analysis of 220 patients revealed that changes in the neutrophil-lymphocyte ratio (NLR) and the presence of liver metastasis were significant predictors of treatment response.
  • The risk model created categorized patients into favorable, intermediate, and poor risk groups, correlating with different objective response rates and overall survival outcomes, suggesting that those in the "poor risk" category might benefit from alternative therapies.
View Article and Find Full Text PDF
Article Synopsis
  • * In a study of 50 platinum-refractory mUC patients, 24% had TLS, but no significant difference in NLR between groups with or without TLS was found.
  • * The research showed that lower NLR patients with TLS had longer overall survival and progression-free survival, while these benefits were not seen in higher NLR patients, suggesting that the presence of TLS may correlate with better treatment outcomes in specific patient groups.
View Article and Find Full Text PDF

Background: There is little evidence of abiraterone acetate (AA) plus prednisone for patients with non-metastatic castration-resistant prostate cancer (nmCRPC). In this study, we conducted a comparative analysis of real-world survival outcomes between AA plus prednisone and enzalutamide (Enz) in patients with nmCRPC, utilizing our consortium dataset.

Materials And Methods: The clinical records of 133 nmCRPC patients treated with first-line Enz or AA plus prednisone were analyzed.

View Article and Find Full Text PDF

Biological sex affects immunity broadly, with recognized effects on the incidence and severity of autoimmune diseases, infections, and malignancies. Consequences of sex on alloimmunity and outcomes in solid organ transplantation are less well defined. Clinical studies have shown that donor and recipient sex independently impact transplant outcomes, which are further modified by aging.

View Article and Find Full Text PDF

Background: Sodium retention causes post-transplant hypertension, and sodium restriction is recommended in kidney transplantation recipients. We investigated the changes in salt intake and age-specific differences in salt intake over the post-transplant periods and considered what guidance is important for salt reduction tailored to individual recipients.

Methods: We calculated salt intake for 38 recipients who underwent kidney transplantation from August 2013 to August 2018 using Tanaka's equation and extracted their blood pressure (BP) levels.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the effectiveness of pembrolizumab in Japanese patients with metastatic urothelial carcinoma, focusing on the time it takes to see a response to the treatment.
  • Results indicated that the objective response rate was 27.1%, with a median time to response of 2.4 months and the best response occurring after 3.1 months.
  • The findings suggest that evaluating treatment response at later stages (like 8 months) is more predictive of overall survival, implying that doctors might benefit from waiting until treatment is closer to completion to assess effectiveness.
View Article and Find Full Text PDF

Cortical bone thickness is important for the mechanical function of bone. Ontogeny, aging, sex, body size, hormone levels, diet, behavior, and genetics potentially cause variations in postcranial cortical robusticity. However, the factors associated with cranial cortical robusticity remain poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares the effectiveness of intra-arterial (IA) cisplatin infusion versus intravenous (IV) infusion in targeting pelvic lymph nodes in a rat model, aiming to improve treatment outcomes for bladder cancer.
  • Results showed that IA infusion resulted in significantly higher concentrations of cisplatin in the bladder and lymphatic tissue compared to the IV infusion, suggesting a more localized delivery of the drug.
  • Findings indicate that IA administration could have a promising role in treating patients with node-positive bladder cancer due to its ability to concentrate the drug effectively in critical areas.
View Article and Find Full Text PDF
Article Synopsis
  • Pembrolizumab is a key treatment for metastatic urothelial carcinoma (mUC) but its effectiveness varies among patients; this study aims to explore how palliative radiation may enhance its survival benefits.
  • A review of a dataset involving 235 mUC patients showed that those who received concurrent palliative radiation with pembrolizumab had significantly longer overall survival (OS) compared to those who did not or those who had radiation before starting pembrolizumab.
  • After adjusting for potential biases, patients treated with concurrent radiation had a median OS of 29 months versus 13 months for those without it, suggesting that combining these treatments might improve outcomes for mUC patients.
View Article and Find Full Text PDF

Serum C-reactive protein (CRP) is known to be a biomarker for systemic inflammatory reactions. In the present study, we sought to measure the predictive value of serum CRP level for metastatic renal cell carcinoma (mRCC) treated with first-line ipilimumab and nivolumab using our real-world clinical dataset including non-clear cell RCC (nccRCC). The clinical record of patients who underwent the first-line ipilimumab plus nivolumab treatment for mRCC including ccRCC and nccRCC from 2018 to 2021 was retrospectively analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the clinical benefits of administering chemotherapy after pembrolizumab treatment in patients with metastatic urothelial carcinoma, focusing on whether it can restore sensitivity to platinum-based drugs.
  • Out of 236 patients who received pembrolizumab, 105 were analyzed for their survival outcomes, comparing those who continued with pembrolizumab versus those who received re-challenging chemotherapy after showing disease progression.
  • Results indicated that patients who received re-challenging chemotherapy had a significantly longer median overall survival (13.9 months) compared to those who continued with pembrolizumab (5.8 months), suggesting the potential effectiveness of this treatment strategy.
View Article and Find Full Text PDF

Purpose Existing options for attaching facial and somato prostheses, such as skin adhesives, are problematic because of microbial colonization and skin irritation. This study aims to evaluate the suitability of adhesive polyurethane gel sheets containing cetylpyridinium chloride (CPC)-montmorillonite (Mont) for prosthesis fastening.Methods Adhesive gel sheets were fabricated as mixtures of base resin (99.

View Article and Find Full Text PDF

Preoperative assessment is essential to prevent inferior alveolar nerve (IAN) injury during surgical extraction of the lower third molar (LM3). Here, we aimed to establish an assessment system to predict IAN injury during surgical extraction of the LM3. We conducted a retrospective cohort study on 115 patients diagnosed as 'high-risk' based on our previous risk assessment method involving three anatomical features of the inferior alveolar canal using computed tomographic (CT) images.

View Article and Find Full Text PDF

Purpose: Most patients with metastatic urothelial carcinoma experience no objective response to pembrolizumab and have poor overall survival (OS). Here, we investigated the prognostic value of fluctuation in the neutrophil-lymphocyte ratio (NLR) at 6 weeks of pembrolizumab treatment, focusing on its association with the achievement of objective response.

Materials And Methods: The clinical records of 177 metastatic urothelial carcinoma patients treated with pembrolizumab were retrospectively analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • Chemoradiation therapy (CRT) is being explored as a potential alternative to total cystectomy (TC) for localized bladder cancer, with pembrolizumab established as a standard treatment for metastatic cases.
  • A study analyzed survival outcomes of patients treated with pembrolizumab after CRT compared to those after TC, finding no significant difference in overall survival or response rates between the two groups.
  • Additionally, the analysis of tumor characteristics revealed no notable differences in PD-L1 profiles or CD274 expression levels between CRT-recurrent and CRT-naïve tumors, indicating that pembrolizumab's efficacy is consistent across treatment backgrounds.
View Article and Find Full Text PDF

This study examined the controlled release of cetylpyridinium chloride (CPC) from a tissue conditioner (TC) containing CPC-montmorillonite (CPC-Mont), the associated antimicrobial activity, and oral mucosa irritation. The CPC release test was performed daily for 28 days in three test solutions: distilled water, 0.2 M NaCl, and 0.

View Article and Find Full Text PDF

Pembrolizumab has emerged as the new standard of care in patients with platinum-refractory metastatic urothelial carcinoma (mUC), whereas the optimal risk stratification to predict survival outcomes is still controversial. We examined a risk model for overall survival (OS) in mUC treated with pembrolizumab using our multi-institutional dataset (212 patients). The median age was 72 years old.

View Article and Find Full Text PDF